Рет қаралды 29
Dr. Rena Callahan highlights the impact of the Breast Cancer Index test on patient compliance in regard to extended endocrine therapy.
Watch the full product theater recording from 2023 San Antonio Breast Cancer Symposium (SABCS): www.hologic.co...
For intended use and limitations, visit breastcancerindex.com. Dr. Rena Callahan is a consultant for Biotheranostics, Inc. Statements reflect the speaker’s own personal views and interpretations.